These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 10582908)

  • 1. In vitro activities of ketolide HMR3647, macrolides, and other antibiotics against Lactobacillus, Leuconostoc, and Pediococcus isolates.
    Zarazaga M; Sáenz Y; Portillo A; Tenorio C; Ruiz-Larrea F; Del Campo R; Baquero F; Torres C
    Antimicrob Agents Chemother; 1999 Dec; 43(12):3039-41. PubMed ID: 10582908
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antimicrobial susceptibility of vancomycin-resistant Leuconostoc, Pediococcus, and Lactobacillus species.
    Swenson JM; Facklam RR; Thornsberry C
    Antimicrob Agents Chemother; 1990 Apr; 34(4):543-9. PubMed ID: 2344161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro activity of the new ketolide HMR3647 in comparison with those of macrolides and pristinamycins against Enterococcus spp.
    Torres C; Zarazaga M; Tenorio C; Portillo A; Saenz Y; Ruiz F; Baquero F
    Antimicrob Agents Chemother; 1998 Dec; 42(12):3279-81. PubMed ID: 9835527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In-vitro activity of the new ketolide antibiotic HMR 3647 against gram-positive bacteria.
    Schülin T; Wennersten CB; Moellering RC; Eliopoulos GM
    J Antimicrob Chemother; 1998 Sep; 42(3):297-301. PubMed ID: 9786468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Susceptibilities of 228 penicillin- and erythromycin-susceptible and -resistant pneumococci to RU 64004, a new ketolide, compared with susceptibilities to 16 other agents.
    Ednie LM; Spangler SK; Jacobs MR; Appelbaum PC
    Antimicrob Agents Chemother; 1997 May; 41(5):1033-6. PubMed ID: 9145864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Susceptibilities of penicillin- and erythromycin-susceptible and -resistant pneumococci to HMR 3647 (RU 66647), a new ketolide, compared with susceptibilities to 17 other agents.
    Pankuch GA; Visalli MA; Jacobs MR; Appelbaum PC
    Antimicrob Agents Chemother; 1998 Mar; 42(3):624-30. PubMed ID: 9517943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro activity of telithromycin (HMR3647), a new ketolide, against clinical isolates of Mycoplasma pneumoniae in Japan.
    Yamaguchi T; Hirakata Y; Izumikawa K; Miyazaki Y; Maesaki S; Tomono K; Yamada Y; Kamihira S; Kohno S
    Antimicrob Agents Chemother; 2000 May; 44(5):1381-2. PubMed ID: 10770785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of antibiotic susceptibility within lactic acid bacteria strains isolated from wine.
    Rojo-Bezares B; Sáenz Y; Poeta P; Zarazaga M; Ruiz-Larrea F; Torres C
    Int J Food Microbiol; 2006 Oct; 111(3):234-40. PubMed ID: 16876896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro activity of ABT-773, telithromycin and eight other antimicrobials against erythromycin-resistant Streptococcus pneumoniae respiratory isolates of children.
    Johnson CN; Benjamin WH; Gray BM; Crain MC; Edwards KM; Waites KB
    Int J Antimicrob Agents; 2001 Dec; 18(6):531-5. PubMed ID: 11738340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro activities of the new ketolide antibiotics HMR 3004 and HMR 3647 against Streptococcus pneumoniae in Germany.
    Reinert RR; Bryskier A; Lütticken R
    Antimicrob Agents Chemother; 1998 Jun; 42(6):1509-11. PubMed ID: 9624505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro activities of the novel ketolide telithromycin (HMR 3647) against erythromycin-resistant Streptococcus species.
    Jalava J; Kataja J; Seppälä H; Huovinen P
    Antimicrob Agents Chemother; 2001 Mar; 45(3):789-93. PubMed ID: 11181362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of in vitro activities of ketolides, macrolides, and an azalide against the spirochete Borrelia burgdorferi.
    Hunfeld KP; Wichelhaus TA; Rödel R; Acker G; Brade V; Kraiczy P
    Antimicrob Agents Chemother; 2004 Jan; 48(1):344-7. PubMed ID: 14693564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antimicrobial susceptibilities of Lactobacillus, Pediococcus and Lactococcus human isolates and cultures intended for probiotic or nutritional use.
    Klare I; Konstabel C; Werner G; Huys G; Vankerckhoven V; Kahlmeter G; Hildebrandt B; Müller-Bertling S; Witte W; Goossens H
    J Antimicrob Chemother; 2007 May; 59(5):900-12. PubMed ID: 17369278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibiotic resistance of Lactobacillus pentosus and Leuconostoc pseudomesenteroides isolated from naturally-fermented Aloreña table olives throughout fermentation process.
    Casado Muñoz Mdel C; Benomar N; Lerma LL; Gálvez A; Abriouel H
    Int J Food Microbiol; 2014 Feb; 172():110-8. PubMed ID: 24370969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The in vitro activity of ABT773, a new ketolide antimicrobial agent.
    Andrews JM; Weller TM; Ashby JP; Walker RM; Wise R
    J Antimicrob Chemother; 2000 Dec; 46(6):1017-22. PubMed ID: 11102425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro activities of two ketolides, HMR 3647 and HMR 3004, against gram-positive bacteria.
    Malathum K; Coque TM; Singh KV; Murray BE
    Antimicrob Agents Chemother; 1999 Apr; 43(4):930-6. PubMed ID: 10103202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro activity of a new ketolide antibiotic, HMR 3647, against Chlamydia pneumoniae.
    Roblin PM; Hammerschlag MR
    Antimicrob Agents Chemother; 1998 Jun; 42(6):1515-6. PubMed ID: 9624507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro activity of RU 64004, a new ketolide antibiotic, against gram-positive bacteria.
    Schülin T; Wennersten CB; Moellering RC; Eliopoulos GM
    Antimicrob Agents Chemother; 1997 May; 41(5):1196-202. PubMed ID: 9145901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro activity of ABT-773 versus macrolides and quinolones against resistant respiratory tract pathogens.
    Dubois J; St -Pierre C
    Diagn Microbiol Infect Dis; 2001; 40(1-2):35-40. PubMed ID: 11448561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antimicrobial susceptibility of non-enterococcal intrinsic glycopeptide-resistant Gram-positive organisms.
    Vay C; Cittadini R; Barberis C; Hernán Rodríguez C; Perez Martínez H; Genero F; Famiglietti A
    Diagn Microbiol Infect Dis; 2007 Feb; 57(2):183-8. PubMed ID: 17049799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.